Rymed Tablet, Coated
NDC Package 0485-0080-01
Package Information
Rymed (dexchlorpheniramine maleate and phenylephrine hydrochloride) tablets is do not exceed recommended dosage.Adults and children 12 years of age and over:1 tablet every 4 hours, not to exceed 6 tablets in 24 hours, or as directed by a doctorChildren 6 to under 12 years of age:1/2 tablet every 4 hours, not to exceed 3 tablets in 24 hours, or as directed by a doctorChildren under 6 years of age:Consult a doctor. This formulation utilizes a tablet, coated delivery system. Marketed by Edwards Pharmaceuticals, Inc., this product is identified by NDC 0485-0080 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 2184108 - dexchlorpheniramine maleate 2 MG / phenylephrine HCl 10 MG Oral Tablet
- RxCUI: 2184108 - dexchlorpheniramine maleate 2 MG / phenylephrine hydrochloride 10 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0485 - Edwards Pharmaceuticals, Inc.
- 0485-0080 - Rymed
- 0485-0080-01 - 100 TABLET, COATED in 1 BOTTLE, PLASTIC
- 0485-0080 - Rymed
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0485-0080-01 identifies a specific commercial package of 100 tablet, coated in 1 bottle, plastic of Rymed, a human over the counter drug labeled by Edwards Pharmaceuticals, Inc.. This tablet, coated is formulated for oral use and contains dexchlorpheniramine maleate; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Edwards Pharmaceuticals, Inc. on November 15, 2011. The current certification is valid through December 31, 2026.
How is this Edwards Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00485008001. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.